Internal Medicine, Hematology & Oncology · Guaynabo, PR
NPI
1831181452
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
12 Ave Parque de Los Ninos, Box 164
Guaynabo, PR, 00969
Phone (787) 383-6687
Medicare paid, 2024
$447K
17,413 services
Medicare patients, 2024
51
Average age 75
Drug cost, 2024
$4.1M
1,394 prescriptions
Company payments, 2025
$1,783
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael D Betancourt Garcia was code 96415 (chemotherapy administration), 451 times for 11 patients. In total Rafael D Betancourt Garcia billed 17,413 services in 31 codes, and Medicare paid $447K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-07-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96415 Chemotherapy Administration | Office | 451 | 11 | $18.35 | $8,275 |
| 96413 Chemotherapy Administration | Office | 139 | 11 | $73.66 | $10K |
| 99213 Office E&M - Established | Office | 116 | 35 | $38.19 | $4,430 |
| 99203 Office E&M - New | Office | 22 | 22 | $44.52 | $979 |
By year: 2022 $46K for 6,102 services; 2023 $462K for 20,570 services; 2024 $447K for 17,413 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael D Betancourt Garcia prescribed most often to Medicare patients was Anastrozole, with 186 prescriptions and refills. In total Rafael D Betancourt Garcia wrote 1,394 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 186 | 273 | 34 | $3,681 |
| Pantoprazole Sodium Generic | 167 | 189 | 54 | $1,256 |
| Ondansetron Hcl Generic | 137 | 139 | 64 | $1,376 |
| Prochlorperazine Maleate Generic | 121 | 121 | 51 | $1,880 |
| Revlimid Lenalidomide | 116 | 116 | 14 | $2.1M |
| Retacrit Epoetin Alfa-Epbx | 48 | 48 | 34 | $82K |
| Abiraterone Acetate Generic | 43 | 43 | Under 11 | $65K |
| Dexamethasone Generic | 42 | 42 | Under 11 | $829 |
| Prednisone Generic | 42 | 42 | Under 11 | $214 |
| Hydroxyurea Generic | 34 | 36 | Under 11 | $1,221 |
| Omeprazole Generic | 32 | 40 | 11 | $166 |
| Imatinib Mesylate Generic | 29 | 29 | Under 11 | $51K |
| Tamoxifen Citrate Generic | 28 | 46 | Under 11 | $1,609 |
| Gabapentin Generic | 25 | 35 | Under 11 | $375 |
| Nubeqa Darolutamide | 24 | 24 | Under 11 | $339K |
Brand drugs: - claims; generic drugs: 1,057 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael D Betancourt Garcia $1,783 ($1,783 in general payments such as food, travel and fees) from 19 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $266.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $266 |
| Janssen Pharmaceuticals, Inc JNJ | 11 | $253 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $209 |
| Merck Sharp & Dohme LLC MRK | 10 | $197 |
| Pbg Puerto Rico LLC | 7 | $164 |
| Abbvie Inc. ABBV | 7 | $154 |
| GlaxoSmithKline, LLC. GSK | 3 | $74.49 |
| Bayer Puerto Rico Inc. BAYN.DE | 3 | $67.96 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 3 | $66.75 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $47.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.